|  | 
| MechanismTfR1 antagonists | 
| Active Org.- | 
|  | 
| Active Indication- | 
|  | 
| Drug Highest PhasePending | 
| First Approval Ctry. / Loc.- | 
| First Approval Date- | 
|  | 
| MechanismFerritin inhibitors | 
| Active Org.- | 
|  | 
| Active Indication- | 
|  | 
| Drug Highest PhasePending | 
| First Approval Ctry. / Loc.- | 
| First Approval Date- | 
|  | 
| MechanismFerritin inhibitors | 
| Active Org.- | 
|  | 
| Active Indication- | 
|  | 
| Drug Highest PhasePending | 
| First Approval Ctry. / Loc.- | 
| First Approval Date- | 
100 Clinical Results associated with MABLife SAS
0  Patents (Medical) associated with MABLife SAS
100 Deals associated with MABLife SAS
100 Translational Medicine associated with MABLife SAS